Introduction
============

Protein secretion systems play central roles in the export or import of macromolecules in both prokaryotic and eukaryotic cells. In Gram-negative bacteria, the translocation of proteins across the inner (or cytoplasmic) membrane (IM)[^2^](#FN3){ref-type="fn"} is mediated by either the general secretory (Sec) pathway ([@B1]) or the twin-arginine translocation (Tat) pathway ([@B2]). In addition, at least six types of specialized protein secretion systems, type I to type VI (T1SS--T6SS) have evolved in Gram-negative bacteria for protein/DNA transport in response to specific environmental cues ([@B3]--[@B9]).

The most recently discovered T6SS is highly conserved and widely distributed in pathogenic Proteobacteria ([@B9]--[@B13]). T6SSs are involved in virulence or anti-virulence, biofilm formation, and cytotoxicity to eukaryotic or prokaryotic hosts, suggesting the diversified functions of this secretion system ([@B14]--[@B17]). Secretion of hemolysin-coregulated protein (Hcp) to the extracellular milieu is the hallmark of a functional T6SS. A unique feature of Hcp and another commonly observed secreted extracellular protein (or exoprotein), VgrG ([v]{.ul}aline-[g]{.ul}lycine [r]{.ul}epeat protein [G]{.ul}), is that they both lack a recognizable Sec- or Tat-dependent signal peptide and are an integral part of the secretion apparatus because of their mutual requirement for secretion ([@B18]--[@B20]). Hcp forms a hexamer ring with a 40 Å internal pore ([@B21]) and is capable of stacking in a tube-like structure *in vitro* ([@B22]). Remarkably, the structure and sequence analogy of Hcp ([@B23]) and VgrG ([@B19], [@B24]) to tail tube gp19 and spike gp5/gp27 of the T4 bacteriophage, respectively, has led to a proposed Hcp-VgrG phage tail-like structure. Moreover, two of the *Vibrio cholerae* T6SS components, TssB (VipA) and TssC (VipB), following the general type VI secretion (Tss) nomenclature ([@B25]), form a cogwheel-like tubular complex, which is also structurally similar to the T4 tail sheath protein ([@B26], [@B27]). In addition, T6SS also encodes components with sequence similarity to T4 phage gp25, a baseplate protein with lysozyme activity ([@B23]), even though no lysozyme activity could be detected ([@B28]). Therefore, it is conceivable that T6SS may assemble into an inverted phage tail-like surface appendage similar to the T3S needle or T4S pilus ([@B29]). However, whether and how this postulated structure is assembled *in vivo* and the molecular mechanisms underlying Hcp/VgrG secretion across double membranes remain largely unknown.

Bacterial secretion systems generally require ATPases or proton motive force to energize assembly of the secretion machinery and/or substrate translocation ([@B30]--[@B34]). In T6SSs, two proteins with known ATPase activity or nucleotide binding site may function as energizers. The AAA+-type ATPase TssH (ClpV) mediates the remodeling of cogwheel-like TssB/TssC (VipA/VipB) tubules via ATP hydrolysis, which is crucial for Hcp secretion ([@B26], [@B35]). The IcmF family protein TssM is a conserved T6SS component and putative NTPase in which the importance of its Walker A nucleotide binding site for Hcp secretion remains controversial ([@B20], [@B36]). TssM is a polytopic IM protein interacting with another conserved T6SS protein, TssL, a bitopic IcmH/DotU family IM protein, to form an IM protein complex ([@B36]). However, the functional role of TssM and TssL in Hcp secretion remains unclear.

Here, we have characterized the biochemical functions of TssM and its interacting protein, TssL, for their mechanistic roles in Hcp secretion in T6SS of the plant pathogenic bacterium *Agrobacterium tumefaciens*. We provide compelling evidence that TssM exhibits ATPase activity and its ATP hydrolysis but not ATP binding activity is crucial for assembly of TssM-TssL-Hcp IM complex and energizes the secretion of Hcp from *A. tumefaciens*. The direct interaction of Hcp with the periplasmic domain of TssL further suggested that TssM might function as an energizer to trigger periplasmic Hcp secretion across the OM.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Strains, Plasmids, and Primers

[Table 1](#T1){ref-type="table"} lists all of the strains and plasmids used in this study. The primers used are listed in [supplemental Table S1](http://www.jbc.org/cgi/content/full/M111.301630/DC1). *A. tumefaciens* TssM and TssL were named previously ImpL and ImpK, respectively ([@B36]). The plasmids were maintained by the addition of 50 μg/ml gentamycin and 200 μg/ml spectinomycin for *A. tumefaciens* and 100 μg/ml ampicillin, 100 μg/ml spectinomycin, 50 μg/ml chloramphenicol, and 25 μg/ml gentamycin for *Escherichia coli*.

###### 

**Strains and plasmids used in this study**

  Strain/Plasmid                         Genotype/Description                                                                                                  Source
  -------------------------------------- --------------------------------------------------------------------------------------------------------------------- ---------------
  *E. coli*                                                                                                                                                    
      EN2                                *E. coli* BL21 (DE3) *dnaK* deleted strain                                                                            Ref. [@B39]
      BL21(DE3)                          Overexpressing proteins driven by T7 promoter                                                                         Ref. [@B74]
                                                                                                                                                               
  *A. tumefaciens*                                                                                                                                             
      C58                                Wild type virulent strain containing nopaline-type Ti-plasmid pTiC58                                                  Eugene Nester
      Δ*tssM*                            In-frame deletion of *tssM* (*impL*) in C58                                                                           Ref. [@B36]
      Δ*tssM*Δ*tssL*                     In-frame deletion of *tssM* (*impL*) and *tssL* (*impK*) in C58                                                       This study
                                                                                                                                                               
  **Plasmids**                                                                                                                                                 
      pRL662                             Gm^R^, vector derived from pBBR1MCS-2, *lac* promoter expression vector                                               Ref. [@B75]
      pTrc200                            Sp^R^, pVS1 origin *lacI*^q^, *trc* promoter expression vector                                                        Ref. [@B76]
      pTrc200HA                          Sp^R^, HA sequence inserted between PstI and HindIII site of pTrc200                                                  This study
      pET-22b(+)                         Ap^R^, overexpression vector to generate C-terminal His-tagged protein driven by T7 promoter                          Novagen
      pACYCDuet-1                        Cm^R^, vector for coexpression of two target genes                                                                    Novagen
      pTssM                              Gm^R^, pRL662 expressing TssM (ImpL)                                                                                  Ref. [@B36]
      pTssL                              Sp^R^, pTrc200 expressing TssL (ImpK)                                                                                 This study
      pTrc-TssL-His                      Sp^R^, pTrc200 expressing His-tagged TssL (ImpK)                                                                      This study
      pTssM^G144A/K145A^                 Gm^R^, pRL662 expressing TssM (ImpL) with both G144A and K145A substitutions                                          Ref. [@B36]
      pTssM^D188A/G191A^                 Gm^R^, pRL662 expressing TssM (ImpL) with both D188A and G191A substitutions                                          This study
      pRL662-Hcp                         Gm^R^, pRL662 expressing Hcp                                                                                          Ref. [@B38]
      pTrc-Hcp                           Sp^R^, pTrc200 expressing Hcp                                                                                         This study
      pET-TssL-His                       Ap^R^, pET-22b(+) overexpressing His-tagged TssL (ImpK)                                                               Ref. [@B36]
      pET-TssL(Peri)-His                 Ap^R^, pET-22b(+) overexpressing periplasmic domain of His-tagged TssL (ImpK)                                         Ref. [@B36]
      pET-TssL(Cyto)-HA                  Ap^R^, pET-22b(+) overexpressing cytoplasmic domain of HA-tagged TssL (ImpK)                                          This study
      pTrc-TssM-HA                       Sp^R^, pTrc200 expressing HA-tagged TssM (ImpL)                                                                       This study
      pET-TssM-His                       Ap^R^, pET-22b(+) overexpressing His-tagged TssM (ImpL)                                                               This study
      pET-TssM^G144A/K145A^-His          Ap^R^, pET-22b(+) overexpressing His-tagged TssM (ImpL) with both G144A and K145A substitutions                       This study
      pET-TssM^4PM^-His                  Ap^R^, pET-22b(+) overexpressing His-tagged TssM (ImpL) with G139AG144A K145AT146A substitutions                      This study
      pACYC-TssL-TssM -His               Cm^R^, pACYCDuet-1 co-overexpressing TssL (ImpK) and His-tagged TssM (ImpL)                                           This study
      pACYC-TssL-TssM^G144A/K145A^-His   Cm^R^, pACYCDuet-1 co-overexpressing TssL (ImpK) and His-tagged TssM (ImpL) with both G144A and K145A substitutions   This study
      pACYC-TssL-TssM^D188A/G191A^-His   Cm^R^, pACYCDuet-1 co-overexpressing TssL (ImpK) and His-tagged TssM (ImpL) with both D188A and G191A substitutions   This study
      pET-Hcp-His                        Ap^R^, pET22b overexpressing His-tagged Hcp                                                                           Ref. [@B38]

#### Plasmid Construction and Generation of In-frame Deletion Mutants

All in-frame deletion mutants were generated in *A. tumefaciens* strain C58 via double crossover using the suicide plasmid pJQ200KS ([@B37]) as described ([@B36], [@B38]). For plasmids used in protein purification, the plasmid pET-TssM-His was created by ligating the NdeI/XhoI-digested *tssM* PCR product (primers 1 and 2) into the same site of pET22b-(+). To construct plasmid pET-TssM^G144A/K145A^-His or pET-TssM^4PM^-His, the 1.5-kb NdeI/BamHI-digested *tssM* fragment from the plasmid pET-TssM-His was removed and replaced with the 1.5-kb NdeI/BamHI-digested *tssM* PCR product containing either the G144A/K145A mutation (primers 3a and 3b and primers 4a and 4b) or the G139A/G144A/K145A/T146A mutation (primers 5a and 5b and primers 6a and 6b), respectively. For plasmid pACYC-TssL-TssM-His, the *tssL* PCR product (primers 7a and 7b) was cloned into the NcoI/EcoRI sites of pACYCDUET-1 to create plasmid pACYC-TssL. The *tssM* PCR product (primers 8a and 8b) was cloned into the NdeI/XhoI sites of pACYC-TssL resulting in pACYC-TssL-TssM-His. The plasmids pACYC-TssL-TssM^G144A/K145A^-His (primers 3a and 3b and primers 4a and 4b) and pACYC-TssL-TssM^D188A/G191A^-His (primers 9a and 9b and primers 10a and 10b) were constructed following the procedure described for construction of pET-TssM^G144A/K145A^-His.

For plasmid pTssL, the *tssL* ORF was amplified (primers 21 and 22) and cloned into the NcoI/BamHI sites of pTrc200. For plasmids used in complementation or protein-protein interaction, the plasmid pTssM^D188A/G191A^ was created by replacing the 1.5-kb XhoI/BamHI-digested *tssM* fragment of plasmid pRL662-TssM ([@B36]) with the XhoI/BamHI-digested PCR product (primers 11a and 11b and primers 12a and 12b). For plasmid pTrc-Hcp, the *hcp* ORF was amplified (primers 13 and 14) and cloned into the NcoI/XbaI sites of pTrc200. For plasmid pTrc-TssL(Cyto)-HA, the PCR product of *tssL* (primers 15 and 16) encoding amino acids 1--255 was digested by NdeI/BamHI and cloned into the same site of pTrc200HA. Then, the plasmid pTrc-TssL(Cyto)-HA was used as a template for amplifying the *tssL*(Cyto)-HA PCR product (primers 17 and 18). The PCR product was digested with NdeI/HindIII and ligated into the same site of pET22b-(+) to result in plasmid pET-TssL(Cyto)-HA. For plasmid pTrc-TssM-HA, the *tssM* ORF was amplified (primers 19 and 20) and cloned into the KpnI/XbaI sites of pTrc200HA. For plasmid pTssL-His, the *tssL* ORF with His~6~ sequences was amplified (primers 23 and 24) and cloned into the NcoI/XbaI sites of pTrc200.

#### TssM Protein Purification for ATP Binding and Hydrolysis Activity Assay

His-tagged wild type (WT) TssM protein or its variants were co-expressed with TssL, or His-tagged TssL was expressed alone in *E. coli dnaK* deletion mutant strain EN2 ([@B39]) and purified for ATP binding and the hydrolysis activity assay. The plasmids used in co-expressing WT TssM or its variants with TssL are indicated in each experiment. The strains were grown in Luria broth medium at 30 °C till *A*~600~ = 0.6. Isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside (IPTG) was added to a final concentration of 1 m[m]{.smallcaps}, and growth continued for 4 h at 25 °C. The cells were suspended in lysis buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.3 [m]{.smallcaps} NaCl, 0.1 m[m]{.smallcaps} EDTA, 1 m[m]{.smallcaps} DTT, 10% glycerol, 1 m[m]{.smallcaps} PMSF, and 0.5 mg/ml lysozyme) supplemented with 0.1 mg/ml DNase and 0.1 mg/ml RNase. After two passages through a French pressure cell at 16,000 p.s.i., the unbroken cells were removed by centrifugation at 20,000 × *g* for 15 min at 4 °C. The supernatant was further centrifuged at 150,000 × *g* for 1 h at 4 °C. The pellet, enriched with membrane proteins, was incubated in extraction buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.1 m[m]{.smallcaps} EDTA, 0.1 [m]{.smallcaps} NaCl, 10% glycerol, 1 m[m]{.smallcaps} DTT, and 2% *n*-dodecyl-β-[d]{.smallcaps}-maltoside (DDM)) overnight and centrifuged at 150,000 × *g* for 1 h to obtain the supernatant containing the DDM-soluble membrane proteins. The DDM-solubilized proteins were further adjusted to final buffer condition (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.3 [m]{.smallcaps} NaCl, 10% glycerol, 0.1% DDM, and 10 m[m]{.smallcaps} imidazole) before preincubation with Ni^2+^-nitrilotriacetic acid (Ni-NTA) resin for 1 h. The precleared protein sample was loaded onto an NTA column, washed with washing buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.15 [m]{.smallcaps} NaCl, 10% glycerol, 0.05% DDM, and 15 m[m]{.smallcaps} imidazole), and eluted with elution buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.05 [m]{.smallcaps} NaCl, 10% glycerol, 0.05% DDM, and 200 m[m]{.smallcaps} imidazole). The eluted fractions were concentrated and exchanged to a buffer containing 50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.05 [m]{.smallcaps} NaCl, 10% glycerol, and 0.05% DDM using either 100-kDa Microcon cut-offs (Millipore YM-100) for WT TssM and its variants or 30-kDa Microcon cut-offs for negative control TssL-His. The purified WT TssM and its variants were kept on ice until ATP binding or the ATPase activity assay within 3 days after purification to avoid protein degradation and loss of activity.

#### ATP Binding Assay

The TssM nucleotide binding activity was determined using a fluorescent ATP analog (TNP-ATP; Molecular Probes, Inc.) monitored by a Jasco FP-6500 spectrofluorometer. Purified TssM proteins were resuspended at 0.25 μ[m]{.smallcaps} in reaction buffer (50 m[m]{.smallcaps} Tris-HCl, pH 7.5, 0.05 [m]{.smallcaps} NaCl, 0.05% DDM) in the presence or absence of 2 μ[m]{.smallcaps} TNP-ATP and incubated at room temperature for 1 min. Fluorescence was excited at 410 nm, and emission was scanned in the range of 470 to 650 nm. All spectra were corrected by subtracting the background fluorescence emitted from buffer control.

#### ATP Hydrolysis Analysis

ATPase activity was determined using a malachite green assay ([@B40], [@B41]) with minor modifications. Briefly, 8 pmol of protein was resuspended in 120 μl of reaction buffer (50 m[m]{.smallcaps} Tris-HCl, pH 7.5, 1 m[m]{.smallcaps} DTT, 0.1% Nonidet P-40, 5 m[m]{.smallcaps} MgCl~2~, 25 μ[m]{.smallcaps} zinc acetate, 5 m[m]{.smallcaps} potassium acetate, and 1 m[m]{.smallcaps} ATP) and incubated at 37 °C. The reaction mixture was mixed with 480 μl of malachite green reagent (0.03% malachite green hydrochloride, 1 [n]{.smallcaps} HCl, 1.05% ammonium molybdate, and 0.1% Triton X-100) to monitor the release of inorganic phosphate (P~i~). 60 μl of 34% sodium citrate was added to stop the reaction, and further incubated at room temperature for 40 min before reading at 650 nm. Each sample was assayed at 0 and 120 min in triplicate, and the total P~i~ for each reaction was compared with a P~i~ standard curve prepared with K~2~HPO~4~. All readings were corrected by subtracting the background values from "no protein" controls.

#### In Vitro Pulldown Assay of TssL-TssM-HA Complex and Hcp-His

Hcp-His and TssL-TssM-HA complex were purified separately from *E. coli* BL21(DE3) before the *in vitro* pulldown assay. For Hcp-His protein purification, *E. coli* BL21(DE3) harboring Hcp-His plasmid (pET-Hcp-His) was grown at 37 °C until *A*~600~ = 0.5. IPTG was added at 0.4 m[m]{.smallcaps} final concentration, and growth continued for 2 h. The cell pellet resuspended in lysis buffer (20 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.5 [m]{.smallcaps} NaCl, 15 m[m]{.smallcaps} imidazole, 0.2 mg/ml DNase, 0.2 mg/ml RNase, and 1 m[m]{.smallcaps} PMSF) was lysed by a French pressure cell as described above. After removal of the unbroken cells and membranes, the cell lysate was loaded onto an Ni^2+^-NTA affinity column, washed with lysis buffer, and eluted with elution buffer as described above, except 250 m[m]{.smallcaps} imidazole was used. The eluted fraction was loaded onto a Superdex 200 column pre-equilibrated with buffer containing 20 m[m]{.smallcaps} Tris-Cl, pH 7.5, and 0.3 [m]{.smallcaps} NaCl. The fractions containing the Hcp-His peak were pooled and concentrated with 10-kDa Microcon cut-offs. The purified Hcp-His was stored at −20 °C until used for the *in vitro* pulldown assay with the TssL-TssM-HA complex.

For purification of the TssL-TssM-HA protein complex, the *E. coli* BL21(DE3) cells expressing both TssM-HA (pTssM-HA) and TssL (pET-TssL) were grown at 37 °C until *A*~600~ = 0.6 before the addition of IPTG (1 m[m]{.smallcaps} final concentration), and growth was continued for 4 h at 25 °C. The cell pellet was suspended in lysis buffer (50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.3 [m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} EDTA, 1 m[m]{.smallcaps} DTT, 1 m[m]{.smallcaps} PMSF, 0.5 mg/ml lysozyme, 0.2 mg/ml DNase, and 0.2 mg/ml RNase) and lysed by a French pressure cell as described above. The membrane pellet was resuspended in extraction buffer (50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.15 [m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} PMSF, and 1% DDM) and rocked overnight at 4 °C. The DDM-solubilized proteins were incubated with anti-HA-agarose beads (Sigma) at 4 °C for 2 h. After washing with 50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.15 [m]{.smallcaps} NaCl, and 0.05% DDM, the beads containing the TssL-TssM-HA complex were further incubated with 0.04 unit/μl hexokinase and 1 m[m]{.smallcaps} glucose for 15 min at room temperature in buffer containing 50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.15 [m]{.smallcaps} NaCl, 0.05% DDM, and 1 m[m]{.smallcaps} MgCl~2~. After washing with 50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.15 [m]{.smallcaps} NaCl, 0.05% DDM, and 5 m[m]{.smallcaps} MgCl~2~ to remove hexokinase, the TssL-TssM-HA complex retained on the beads was used for a pulldown assay with purified Hcp-His. Then 2.5 μg of purified Hcp-His proteins was added to the 1 ml of anti-HA beads containing the TssL-TssM-HA complex and was aliquotted evenly before incubation with 1 m[m]{.smallcaps} ATP or non-hydrolyzable ATP analog (AMMNP; Sigma) overnight at 4 °C. The beads were washed three times with buffer (50 m[m]{.smallcaps} Tris-Cl, pH 8.0, 0.15 [m]{.smallcaps} NaCl, and 0.05% DDM); 2× Laemmli buffer was added, and the mixture was boiled for 10 min before SDS-PAGE followed by immunoblotting.

#### ATP Measurements

The ATP levels in untreated and arsenate-treated *A. tumefaciens* cells were measured by an ATP bioluminescence assay kit (CLSII; Roche Applied Science). Briefly, 100 μl of cells resuspended in 80% DMSO to *A*~600~ = 1 was mixed with 400 μl of ice-cold H~2~O. The amounts of ATP were measured for luminescence using a luminometer (Lumat LB9507; Berthold Technologies) by mixing 20 μl of the sample with 100 μl of luciferase reagent.

#### Spheroplast Preparation and Protease Susceptibility Assay

*A. tumefaciens* cells grown in AB-MES medium, pH 5.5, ([@B42]) at 25 °C for 6 h until *A*~600~ = 0.3 were treated with 25 m[m]{.smallcaps} sodium arsenate or H~2~O for 1 h. Cells were harvested by centrifugation and washed once with 50 m[m]{.smallcaps} Tris-Cl, pH 7.5. To prepare the spheroplast, the cell pellet was resuspended gently in buffer containing 50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 20% sucrose, 2 m[m]{.smallcaps} EDTA, 0.2 m[m]{.smallcaps} DTT, and 0.5 mg/ml lysozyme and incubated on ice for 1 h. The spheroplasts were treated with *Streptomyces griseus* protease (Sigma) at a final concentration of 25, 50, 75, or 100 μg/ml for 10 min on ice in the presence of 10 m[m]{.smallcaps} MgCl~2~. The reaction was stopped by adding Laemmli buffer to 1× and immediately boiled for 10 min before SDS-PAGE followed by immunoblotting.

#### Pulldown Assay in A. tumefaciens

The membrane fraction from the *A. tumefaciens* Δ*tssM*Δ*tssL* strain complemented with various plasmids (pTssL-His + pTssM, pTssM^G144A/K145A^, pTssM^D188A/G191A^, or pRL662 vector) was prepared as described above for protein purification. Membrane proteins were solubilized with 2% DDM in the presence of 50 m[m]{.smallcaps} Tris-Cl, pH 7.5, and 1 m[m]{.smallcaps} PMSF by rocking overnight at 4 °C. The solubilized membrane proteins were harvested and further diluted to 0.05% of DDM in buffer containing 50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.3 [m]{.smallcaps} NaCl, and 10 m[m]{.smallcaps} imidazole. The protein samples were loaded onto NTA-resin and washed with 10× bed volumes of wash buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.3 [m]{.smallcaps} NaCl, 15 m[m]{.smallcaps} imidazole, and 0.01% DDM). The proteins were eluted with elution buffer (50 m[m]{.smallcaps} Tris-Cl, pH 7.5, 0.15 [m]{.smallcaps} NaCl, 250 m[m]{.smallcaps} imidazole, and 0.01% DDM). The eluted fraction was precipitated with trichloroacetic acid overnight at 4 °C ([@B38]). The trichloroacetic acid pellet was resuspended in 1× Laemmli buffer and analyzed with SDS-PAGE followed by immunoblotting.

#### Hcp Secretion Assay

*A. tumefaciens* cells grown in AB-MES medium, pH 5.5 ([@B42]), at 25 °C for 6 h were used for Hcp secretion assays as described previously ([@B36], [@B38]).

#### Immunoblotting

Immunoblot analysis was performed as described previously ([@B42]) using primary polyclonal antibody against C-terminal TssM (C-TssM) ([@B36]), N-terminal TssL (N-TssL, amino acids 1--255), Hcp ([@B38]), ActC ([@B43]), or GroEL ([@B44]) followed by secondary antibody using horseradish peroxidase-conjugated goat anti-rabbit and detection using the Western Lightning System (PerkinElmer Life Sciences). Chemiluminescent signals were visualized on a high performance chemiluminescence film (GE Healthcare) or by using the BioSpectrum AC Imaging System (Ultra-Violet Products, Ltd.) to detect and quantify the photon intensity of protein signals.

RESULTS
=======

### 

#### TssM Exhibits ATPase Activity, Which Is Crucial for Hcp Secretion

The conservation of the *A. tumefaciens* TssM Walker A motif in IcmF family proteins and the genetic evidence for its requirement in mediating Hcp secretion suggests that TssM functions as an ATPase ([@B36]). However, biochemical evidence for this assumption is lacking. Because TssM is a 128-kDa IM protein with three transmembrane domains ([@B36]), it has been a challenging task to purify and maintain the stability of full-length TssM fused with various fusion proteins or tags (data no shown). Nonetheless, we were able to obtain full-length TssM-His with high purity within 3 days after purification even though the proteolysis of full-length TssM could not be completely eliminated ([Fig. 1](#F1){ref-type="fig"}*A*). The *E. coli dnaK* mutant strain EN2 ([@B39]) was used to overexpress and purify TssM-His in the presence of TssL, which stabilizes TssM in *A. tumefaciens* ([@B36]) to avoid contamination of the *E. coli* DnaK ATPase during purification. The His-tagged wild type TssM (TssM^WT^) and the Hcp secretion-deficient Walker A mutation variant, TssM^G144A/K145A^ (TssM^mWA^), were purified in parallel by extraction from *E. coli* membranes with nonionic detergent DDM and preincubation with nickel resin to remove nonspecific binding proteins before purification on a nickel resin column. Purified WT TssM (TssM^WT^) possesses ATP binding activity, as evidenced by the increased fluorescence emission intensity upon binding to the fluorescent ATP analog TNP-ATP ([@B45]--[@B47]), and it exhibited ATP hydrolysis activity ([Fig. 1](#F1){ref-type="fig"}, *B* and *C*). Surprisingly, the Walker A variant, TssM^mWA^, retained significant albeit lower ATP binding and hydrolysis activity as compared with TssM^WT^ ([Fig. 1](#F1){ref-type="fig"}, *B* and *C*).

![**TssM binds and hydrolyzes ATP.** *A*, DDM-extracted membrane proteins from *E. coli* strain EN2 co-expressing WT or variants of TssM-His (pET-TssM-His, pET-TssM^G144A/K145A^-His, or pET-TssM^G139A/G144A/K145A/T146A^-His) with TssL (pTssL) were purified by Ni-NTA resin. The purity of wild type TssM-His (TssM^WT^), TssM^G144A/K145A^-His (TssM^mWA^), and TssM^G139A/G144A/K145A/T146A^-His (TssM^mWA(4PM)^) used for ATP binding and hydrolysis assays was examined by Coomassie Blue-stained SDS-PAGE. The sizes of the molecular mass standards (in kDa; Fermentas Inc.) are indicated. *B*, ATP binding activity of WT and its variants. Fluorescence spectra of TNP-ATP bound to WT and its variants were detected in the range of 470 to 650 nm. The spectrum for each sample is indicated as WT TssM-His (*black*, TssM^WT^ +TNP-ATP), TssM^G144A/K145A^-His (*red*, TssM^mWA^ +TNP-ATP), TssM^G139A/G144A/K145A/T146A^-His (*yellow*, TssM^mWA(4PM)^ +TNP-ATP), or TNP-ATP alone (*pink*). At least three independent experiments were performed for which representative data are shown. *C*, ATP hydrolysis activity of WT and its variants. The ATP hydrolysis activity was determined using a malachite green assay to measure the released free inorganic phosphate upon ATP hydrolysis. Average values for ATP hydrolysis activity from three independent experiments are shown with standard deviations.](zbc0201206010001){#F1}

To determine whether the detected ATP binding and hydrolysis activities of the Walker A variant derived from contaminating ATPases co-purified from *E. coli*, we generated an additional TssM variant expressing the full-length protein with mutations in two additional conserved amino acids in the Walker A motif of TssM (TssM^mWA(4PM)^: G139A/G144A/K145A/T146A). Further reduction of TssM^mWA(4PM)^ in ATP binding and hydrolysis activities suggested that TssM^mWA^ indeed does not completely lose its activity in ATP binding and hydrolysis. Because this Walker A variant, TssM^mWA^, caused the loss of Hcp secretion from *A. tumefaciens* ([@B36]), we suggest that TssM exhibits ATPase activity and its full ATPase activity is required to mediate Hcp secretion.

#### Hcp Interacts Directly with TssL but Not TssM

The importance of TssM ATPase activity in mediating Hcp secretion motivated us to investigate whether TssM interacts with Hcp and functions as an energizer to drive Hcp secretion across bacterial membrane. However, no evidence for an interaction between TssM and Hcp was detected by co-immunoprecipitation of TssM tagged with HA in *E. coli* co-expressing Hcp ([Fig. 2](#F2){ref-type="fig"}*A*). Because TssM forms a protein complex with TssL ([@B36]), we then tested whether Hcp might interact with TssL. Indeed, TssL-His could pull down Hcp from *E. coli* that co-expressed both TssL-His and Hcp ([Fig. 2](#F2){ref-type="fig"}*B*). As a control, no Hcp was detected in the bound fraction purified from *E. coli* expressing Hcp alone.

![**Interaction studies of Hcp with TssL and TssM.** *A*, the cell lysate of *E. coli* co-expressing Hcp with full-length TssM tagged with HA (TssM-HA) was subjected to co-immunoprecipitation using anti-HA beads. *B*, the cell lysate of *E. coli* expressing Hcp alone or in the presence of full-length TssL tagged with His (TssL-His), the C-terminal periplasmic domain of TssL-His (TssL(Peri)-His), or the N-terminal cytoplasmic domain of TssL (TssL(Cyto)-HA) were purified by either Ni^2+^-NTA affinity chromatography or co-immunoprecipitation using anti-HA beads. The load (*L*), flow-through (*F*) and washed (*W*) and bound (*B*) fractions were analyzed by immunoblotting with antisera against C-TssM, N-TssL, Hcp, or His~6~ (for TssL(Peri)-His), respectively. The sizes of the molecular mass standards (kDa) are indicated.](zbc0201206010002){#F2}

To dissect the Hcp interaction domain of TssL, we co-expressed Hcp with the N-terminal cytoplasmic domain of TssL (TssL(Cyto)-HA) or the C-terminal periplasmic domain of TssL (TssL(Peri)-His) in *E. coli*. Hcp co-eluted with the periplasmic domain of TssL-His in the bound fraction ([Fig. 2](#F2){ref-type="fig"}*B*). In contrast, no Hcp was detected in the bound fractions purified from *E. coli* co-expressing TssL(Cyto)-HA with Hcp. From this data, we concluded that Hcp interacts specifically with the periplasmic domain of TssL.

#### Full ATPase Activity of TssM Is Crucial for Assembly of TssM-TssL-Hcp Complex

The previously shown TssM-TssL interaction ([@B36]) and our current discovery of a TssL-Hcp interaction in *E. coli* urged us to investigate whether Hcp interacts with the TssM-TssL IM protein complex in *A. tumefaciens*, and if so, whether the ATPase activity of TssM plays a role in this process. To answer this question, we performed a pulldown assay in the *A. tumefaciens* Δ*tssM*Δ*tssL* double mutant expressing TssL-His either in the presence or absence of WT TssM^WT^ or Walker A variant TssM^mWA^. The protein complexes were extracted by DDM from the membrane fraction followed by Ni^2+^-resin purification. TssL-His was able to pull down Hcp in the presence or absence of TssM in *A. tumefaciens* ([Fig. 3](#F3){ref-type="fig"}). However, although TssL-His could pull down either TssM^WT^ or TssM^mWA^ at similar levels, only trace amounts of Hcp could be pulled down by TssL-His from *A. tumefaciens* expressing TssM^mWA^ as compared with that expressing TssM^WT^ ([Fig. 3](#F3){ref-type="fig"}). These data suggested that the formation of the TssM-TssL complex is independent of TssM ATPase activity, whereas its full ATPase activity is important for the formation of the TssM-TssL-Hcp IM complex in *A. tumefaciens*.

![**Full ATPase activity of TssM is crucial for assembly of TssM-TssL-Hcp complex.** Membrane fractions isolated from the *A. tumefaciens* Δ*tssM*Δ*tssL* double mutant expressing TssL-His alone or in the presence of WT TssM (TssM^WT^) or TssM^G144A/K145A^ (TssM^mWA^) were solubilized with DDM. The DDM-solubilized membrane proteins were loaded onto Ni^2+^-NTA resin to purify TssL-His and its interacting partner, TssM. The load (*L*), flow-through (*F*) and washed (*W*) and bound (*B*) fractions were analyzed by immunoblotting with antisera against C-TssM, N-TssL, and Hcp, respectively. The sizes of the molecular mass standards (kDa) are indicated.](zbc0201206010003){#F3}

#### Cellular ATP Levels Modulate TssM Conformation and TssM-TssL-Hcp Complex Formation

It is plausible that ATP binding or hydrolysis of TssM may induce a structural transition for promoting the interaction of TssL and Hcp. To test this possibility, we monitored the conformational change of TssM by its susceptibility to protease digestion, an assay that has been used to detect the VirB10 and TonB conformational switch under energy-dissipated conditions ([@B48], [@B49]). *A. tumefaciens* cells were treated with either H~2~O or arsenate to dissipate intracellular ATP without affecting transmembrane potential ([@B48]), and the spheroplasts were prepared for the protease susceptibility assay. As expected from its topology ([@B36]), TssM was prone to protease digestion, and an increase in protease concentration caused the reduction of full-length TssM along with the presence of truncated TssM. Arsenate treatment was able to deplete about 80% of the cellular ATP level and increased TssM susceptibility to protease as compared with that of the H~2~O-treated condition ([Fig. 4](#F4){ref-type="fig"}*A*). As a control, the cytoplasmic GroEL protein remained resistant to protease digestion in the presence or absence of arsenate, demonstrating that treatment with arsenate did not cause detectable nonspecific cell lysis or proteolysis. The result, that TssM was more resistant to protease digestion at high intracellular ATP levels, indicated that TssM undergoes a conformational switch between the ATP-bound and unbound state.

![**Cellular ATP levels modulate TssM conformation and TssM-TssL-Hcp complex formation.** *A*, spheroplasts prepared from arsenate-treated (*Ars*) or untreated (H~2~O) *A. tumefaciens* WT C58 cells were incubated with different protease concentrations. The level of susceptibility or resistance to protease was analyzed by immunoblotting with antisera against C-TssM and GroEL. Cytoplasmic GroEL serves as an internal control, as its protein level is not affected by energy depletion and resistance to protease. The cellular ATP levels were quantified and presented as the ratio relative to the H~2~O-treated control. *B*, detection of TssL-His-Hcp complex formation in energy-depleted condition. The *A. tumefaciens* Δ*tssM*Δ*tssL* double mutant co-expressing TssM in the absence or presence of TssL-His was treated with arsenate or H~2~O followed by DDM extraction of isolated membrane fractions. The DDM-soluble membrane proteins were purified by Ni^2+^-NTA affinity chromatography (*left panel*). The formation of TssL-His-Hcp complexes was analyzed by immunoblotting with antisera against C-TssM and Hcp, respectively. The relative photon intensity of Hcp used for pulldown or bound to the same amount of purified TssL-His from H~2~O or arsenate-treated cells was quantified as described under "Experimental Procedures." The conformational change of TssM in the Δ*tssM*Δ*tssL* double mutant complemented with TssL-His and TssM was monitored by protease susceptibility, revealing the same susceptibility patterns as the WT C58 strain (*right panel*). The cellular ATP levels were quantified and presented as the ratio relative to the H~2~O-treated control.](zbc0201206010004){#F4}

We next determined whether cellular ATP levels affect the formation of the TssM-TssL-Hcp complex, which may be modulated by the conformational switch of TssM. The Δ*tssM*Δ*tssL* mutant complemented with pTssM and pTssL-His plasmids was treated with either H~2~O or arsenate prior to the pulldown assay. Similar to the observation in the WT strain ([Fig. 4](#F4){ref-type="fig"}*A*), TssM in the complemented strain revealed higher susceptibility to protease in an ATP-depleted condition ([Fig. 4](#F4){ref-type="fig"}*B*, *right panel*). By quantitative immunoblot analysis, the relative protein signals of Hcp to TssL-His used for the pulldown assay from the cells treated with either H~2~O or arsenate were detected at a similar ratio (14.4 *versus* 13.7). In the ATP-depleted condition, we consistently detected only ∼50% of Hcp proteins that were pulled down by TssL-His as compared with that of Hcp bound by the same amount of TssL-His from H~2~O-treated cells (0.21 *versus* 0.11; [Fig. 4](#F4){ref-type="fig"}*B*, *left panel*). As a control, no Hcp was detected in the bound fraction in the absence of TssL-His. Taken together, the cellular ATP levels regulate both a conformational switch in TssM and efficient assembly of the TssM-TssL-Hcp IM complex.

#### TssM Possesses a Walker B Motif That Is Crucial for ATP Hydrolysis

The retention of ATP binding and hydrolysis activities exhibited by the Walker A variant, TssM^mWA^ ([Fig. 1](#F1){ref-type="fig"}, *B* and *C*), motivated us to determine whether other motifs in addition to Walker A may contribute to these activities. By careful sequence inspection of TssM, we identified a putative Walker B motif that is highly conserved among T6SS orthologs and known GTPase family members. The identified Walker B motif contains a signature sequence, *hhhh*D*XX*G, to coordinate Mg^2+^, which is required for ATP hydrolysis. Interestingly, a distal (N/T)K*X*D, which provides specificity for guanine over other nucleotide bases ([@B50], [@B51]), was also identified ([Fig. 5](#F5){ref-type="fig"}*A*).

![**TssM possesses a Walker B motif required for its ATP hydrolysis.** *A*, Walker A, Walker B, and potential GTP-specific motifs were revealed by amino acid sequence alignment of selected T6SS TssM orthologs and other GTPase family members. The conserved amino acid residues of each motif are *highlighted*; the *arrowheads* indicate the amino acids targeted for mutagenesis. The proteins used for alignments are indicated in the order of their protein name, organism, and Genbank^TM^ accession number. *At*, *A. tumefaciens* [C58](C58); *PA*, *P. aeruginosa* [PAO1](PAO1); *Vc*, *V. cholerae* [O1](O1); *Ah*, *A. hydrophila* [ATCC 7966](ATCC7966); *Et*, *E. tarda* [PPD130/91](PPD130/91); *Ec*, *E. coli* [CT18](CT18); *Bs*, *Bacillus subtilis. B*, DDM-extracted membrane proteins from *E. coli* EN2 strain expressing the WT or a variant of TssM-His (TssM^WT^: pACYC-TssL-TssM-His; TssM^mWA^: pACYC-TssL-TssM^G144A/K145A^-His; TssM^mWB^: and pACYC-TssL-TssM^D188A/G191A^-His) or TssL-His (TssL: pET-TssL-His) were purified in parallel using Ni-NTA resin. The purity of TssM^WT^, TssM^mWA^, TssM^mWB^, and TssL used for ATP binding and hydrolysis assays was examined by Coomassie Blue-stained SDS-PAGE. The sizes of the molecular mass standards (kDa; Fermentas) are indicated. *C*, ATP binding activity of TssM and its variants. Fluorescence spectra of TNP-ATP bound to TssM and its variants were detected in the range of 470 to 650 nm. The spectrum for each sample was indicated as WT TssM-His (*black*, TssM^WT^ +TNP-ATP), TssM^G144A/K145A^-His (*red*, TssM^mWA^ +TNP-ATP), TssM^D188A/G191A^-His (*blue*, TssM^mWB^ +TNP-ATP), TssL-His (*yellow*, TssL +TNP-ATP), or TNP-ATP alone (*pink*). *D*, ATP hydrolysis activity of TssM and its variants. ATP hydrolysis activity was determined using the malachite green assay to measure the free inorganic phosphate released upon ATP hydrolysis. Average values for ATP hydrolysis activity from three independent experiments are shown with standard deviations.](zbc0201206010005){#F5}

Thus, we generated mutations in the putative Walker B motif by replacing both conserved Asp-188 and Gly-191 with alanine (Ala) using site-directed mutagenesis. The Walker B mutant (TssM^mWB^: TssM^D188A/G191A^) was overexpressed and purified in parallel with wild type TssM^WT^, Walker A mutant TssM^mWA^, in the presence of TssL for ATPase activity assays ([Fig. 5](#F5){ref-type="fig"}, *B--D*). In addition, His-tagged TssL serving as a negative control (TssL) was purified in parallel. The mutations in the Walker B motif did not result in any loss of ATP binding activity, because the TssM^mWB^ bound the fluorescence TNP-ATP as well as the TssM^WT^ ([Fig. 5](#F5){ref-type="fig"}*C*). In contrast, the hydrolysis activity of TssM^mWB^ was reduced to a similar level to that of TssM^mWA^ ([Fig. 5](#F5){ref-type="fig"}*D*). The fact that much lower ATPase activity was detected from purified TssL as compared with that of TssM^mWA^ and TssM^mWB^ suggested that TssM^mWB^ may not completely lose its ATPase activity. Because TssM^mWB^ retained WT-like ATP binding affinity, its reduced ATP hydrolysis activity should be attributed to the mutations in its Walker B motif. Thus, we discovered that TssM possesses a Walker B motif that functions in ATP hydrolysis.

#### ATP Hydrolysis of TssM Drives TssM-TssL-Hcp Complex Formation and Powers Hcp Secretion

It is clear that the reduced ATP binding/hydrolysis activity of the Walker A variant, TssM^mWA^, caused inefficient assembly of the TssM-TssL-Hcp complex ([Fig. 3](#F3){ref-type="fig"}) and a deficiency in Hcp secretion ([@B36]). However, it remained unanswered whether the structural transition and subsequent Hcp secretion were induced by the ATP binding or the hydrolysis activity of TssM. With the ATP binding/hydrolysis uncoupling of Walker B variant TssM^mWB^ at hand, we asked whether ATP hydrolysis by TssM was required for Hcp secretion. We expressed both TssM^WT^ and TssM^mWB^ in the *A. tumefaciens* Δ*tssM* mutant and performed Hcp secretion assays. The Walker B variant resulted in a complete loss of Hcp secretion to the culture media ([Fig. 6](#F6){ref-type="fig"}*A*), suggesting that TssM mediates Hcp secretion via its ATP hydrolysis activity. To investigate whether the observed conformational switch of TssM is induced by ATP binding or hydrolysis, we performed protease susceptibility assays to determine whether the mutation in the Walker B motif altered protease susceptibility. As shown in [Fig. 6](#F6){ref-type="fig"}*B*, TssM^mWB^ had a similar degree of protease resistance as TssM^WT^, suggesting that the reduced ATP hydrolysis activity did not compromise its ATP-regulated conformational switch. Taken together, we concluded that ATP binding *per se* is able to induce a conformational switch of TssM but is not sufficient to trigger secretion of Hcp.

![**Effect of TssM ATP hydrolysis activity in Hcp secretion and the formation of TssM-TssL-Hcp complex and its conformational change.** *A*, total proteins (*T*) and secreted proteins (*S*) isolated from the *A. tumefaciens* Δ*tssM* mutant harboring plasmids expressing either WT TssM (pTssM^WT^) or Walker B amino acid substitution mutant TssM^D188A/G191A^ (pTssM^mWB^) were analyzed by immunoblotting using antisera against Hcp, C-TssM, and ActC, respectively. ActC serves as a nonsecreted protein control. The positions of the molecular mass markers (in kDa) are indicated. *B*, the *A. tumefaciens* Δ*tssM*Δ*tssL* strain harboring plasmids expressing TssL-His (pTssL-His) with either WT TssM (pTssM) or the Walker B mutant (pTssM^D188A/G191A^) was subjected to the spheroplast protease susceptibility assay at different protease concentrations as indicated. The degree of susceptibility or resistance to protease in Δ*tssM*Δ*tssL* (pTssL-His + pTssM) (WT) and Δ*tssM*Δ*tssL* (pTssL-His + pTssM^D188A/G191A^) (mWB) was analyzed by immunoblotting using antisera against C-TssM and GroEL, respectively. *C*, DDM-soluble membrane proteins isolated from Δ*tssM*Δ*tssL* (pTssL-His + pTssM^WT^) and Δ*tssM*Δ*tssL* (pTssL-His + pTssM^mWB^) were purified by Ni^2+^-NTA affinity chromatography. The load (*L*), flow-through (*F*), and washed (*W*) and bound (*B*) fractions were analyzed by immunoblotting with antisera against N-TssL and Hcp, respectively. The positions of molecular mass markers (in kDa) are indicated. *D*, *in vitro* assay for TssM-TssL-Hcp complex formation in the presence of ATP or non-hydrolyzable ATP. TssL-TssM-HA protein complex purified from *E. coli* membrane was treated with hexokinase to remove cellular ATP and then incubated with purified Hcp-His in the presence or absence of ATP or non-hydrolyzable ATP (AMPPNP) followed by co-immunoprecipitation using anti-HA-agarose beads. The load, flow-through and washed and bound fractions were analyzed by immunoblotting with antisera against N-TssL, Hcp, and C-TssM, respectively. The *right panel* shows the background signal of nonspecific binding of Hcp-His to the beads in absence of TssL-TssM-HA complex.](zbc0201206010006){#F6}

Next, we investigated whether ATP binding is sufficient to recruit Hcp into the TssM-TssL complex for the assembly of a ternary complex. Thus, we performed the pulldown assay using the DDM-extracted membrane complex isolated from the *A. tumefaciens* Δ*tssM*Δ*tssL* mutant expressing either the WT or Walker B variant (TssM^mWB^) in the presence of TssL-His. Although similar amounts of TssM^WT^ or TssM^mWB^ could be pulled down by TssL-His, no Hcp could be detected in the TssM^mWB^-TssL-His complex ([Fig. 6](#F6){ref-type="fig"}*C*). This result suggested that the ATP hydrolysis activity of TssM is crucial for recruiting Hcp into the TssM-TssL IM complex in *A. tumefaciens*. Notably, the ATP binding-induced conformational change in TssM was not sufficient to trigger the formation of the TssM-TssL-Hcp complex.

We noticed that the membrane-associated Hcp protein amounts were lower in either the absence of TssM or the presence of TssM^mWA^ or TssM^mWB^ variants as compared with in the presence of TssM^WT^ ([Figs. 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}*C*). Thus, the deficiency of Hcp to be pulled down by TssL in the mutants could be partly due to the lower abundance of membrane-associated Hcp. Therefore, we designed an *in vitro* pulldown assay to confirm the role of TssM ATP hydrolysis in this ternary complex formation when equal amounts of Hcp were present. We incubated purified Hcp-His with the purified TssL-TssM-HA complex to determine the formation of the ternary complex in the presence of ATP or the non-hydrolyzable ATP analog AMPPNP *in vitro*. The purified TssL-TssM-HA complex was pretreated with hexokinase to eliminate the contaminated ATP co-purified from *E. coli* ([@B52]). By co-immunoprecipitation using anti-HA-agarose beads, we found that much more Hcp-His was co-eluted with the TssL-TssM-HA complex in the presence of ATP than in the presence of AMPPNP or buffer controls ([Fig. 6](#F6){ref-type="fig"}*D*). Because trace amounts of Hcp-His were nonspecifically bound to anti-HA beads in the absence of the TssL-TssM-HA complex, the low levels of Hcp co-immunoprecipitated with TssL-TssM-HA complex may be due to the nonspecific binding of Hcp-His to the beads under this experimental condition. Taken together, our results strongly argue that TssM is an energizer that hydrolyzes ATP to recruit Hcp into the TssM-TssL IM complex, which may be a prerequisite step for Hcp secretion across the OM.

DISCUSSION
==========

TssM and TssL are core T6SS components, which both play essential roles in Hcp secretion in the functional T6SSs identified to date ([@B9]). Despite the conservation of the Walker A motif in TssM ([@B20], [@B36]), its potential function as an NTPase has not been well demonstrated. Previously, we provided genetic evidence indicating the importance of the TssM Walker A motif in Hcp secretion from *A. tumefaciens* ([@B36]). In this work, we have further provided biochemical evidence that TssM exhibits ATPase activity capable of hydrolyzing ATP to recruit Hcp into the TssM-TssL IM complex and powers Hcp secretion across the OM. Based on our findings, we propose a general model of TssM-TssL complex-mediated Hcp secretion across the OM ([Fig. 7](#F7){ref-type="fig"}). We reveal here that TssM undergoes a conformational change upon ATP binding. ATP binding, however, is not sufficient to trigger TssM-TssL-Hcp complex formation and Hcp secretion. Instead, the ATP-bound state is critical for subsequent ATP hydrolysis to recruit Hcp to the periplasmic domain of TssL to form a TssM-TssL-Hcp IM complex. Building this ternary complex could be a prerequisite for Hcp secretion across the OM that is powered by the ATP hydrolysis of TssM.

![**Model of TssM-TssL complex-mediated Hcp secretion across the OM.** TssM (*M*) and TssL (*L*) form a stable IM complex; their interaction is not affected by the ATP binding state of TssM. In the absence of ATP, no conformational change of TssM is induced, and the interaction of TssL with Hcp at the periplasm is prohibited. Upon ATP binding, a conformational change of TssM is induced, but this structural transition is not sufficient to recruit Hcp into the TssM-TssL IM complex. We postulate that ATP hydrolysis of TssM recruits Hcp into the periplasmic domain of TssL. Subsequently, energy derived from ATP hydrolysis drives the translocation of Hcp across the OM. Hexameric Hcp is depicted as interacting with TssL, but the oligomeric states and the origin of Hcp interacting with the TssM-TssL complex remains to be determined. The *green circles* depict ATP, and *red circles* depict ADP.](zbc0201206010007){#F7}

TssM belongs to the P-loop NTPase family, based on the two conserved motifs known as Walker A (G*XXXX*GKT) and Walker B box (*hhhh*(D/E)) ([@B53]). Interestingly, the Walker B motif of TssM has a signature of *hhhh*D*XX*G that belongs to GTPase family proteins ([Fig. 5](#F5){ref-type="fig"}*A*). Apart from the Walker A and B motifs, TssM also contains a highly conserved (N/T)K*X*D motif belonging to the TRAFAC/SIMBI class of GTPases, which provides specificity for guanine over other nucleotide bases ([@B50], [@B51]). Hence, TssM has the hallmarks of a GTP-binding protein, and it is possible that TssM might also utilize GTP as substrate. Indeed, using a malachite green assay, we observed that TssM is capable of hydrolyzing GTP.[^3^](#FN4){ref-type="fn"} However, whether GTP or ATP is the preferred nucleotide and whether GTP binding is physiologically relevant are beyond the scope of this study and await future investigation.

Demonstrating ATP binding and hydrolysis of TssM *in vitro* has been challenging because of the instability of the 128-kDa IM protein with three transmembrane domains ([@B36]). Nevertheless, we have succeeded in demonstrating these activities biochemically upon purifying full-length TssM-His from the membrane fraction of *E. coli* co-expressing TssL to stabilize TssM. Because of the instability of purified TssM variants with either N- or C-terminal truncations or a deletion of the entire Walker A motif ([@B36]) (data not shown), we purified His-tagged TssL to serve as a negative control for ATP binding/hydrolysis activity assays ([Fig. 5](#F5){ref-type="fig"}, *B* and *C*). As compared with the lower ATP binding/hydrolysis activity contributed by TssM^mWA(4PM)^ ([Fig. 1](#F1){ref-type="fig"}, *B* and *C*) and background activity by purified TssL ([Fig. 5](#F5){ref-type="fig"}), we suggest that the mutations in Walker A and B motifs (TssM^mWA^ and TssM^mWB^) may not completely impair ATP binding and hydrolysis activity, respectively. Nevertheless, the concomitant reduction of ATP binding and ATP hydrolysis activities of TssM^mWA^, together with the WT-like ATP binding activity but impaired ATP hydrolysis activity of TssM^mWB^ ([Fig. 5](#F5){ref-type="fig"}), clearly indicated that Walker A and Walker B motifs contribute to the ATP binding and hydrolysis activity of TssM, respectively. Importantly, the loss of Hcp secretion caused by the TssM^mWA^ and TssM^mWB^ variants ([@B36]) ([Fig. 6](#F6){ref-type="fig"}*A*) strongly suggest that both the Walker A and Walker B motifs of TssM are critical for the function of T6SS in *A. tumefaciens*. These data may also explain the contradictory conclusions on the importance of the Walker A motif of TssM orthologs in *A. tumefaciens* and *Edwardsiella tarda* ([@B20], [@B36]). Although the full ATPase activity of TssM is required to mediate Hcp secretion from *A. tumefaciens,* the presumably reduced ATPase activity conferred by the Walker A mutants of *E. tarda* TssM (EvpO) may remain sufficient for Hcp secretion.

The interaction of TssM and TssL in the IM is apparently independent of ATP binding/hydrolysis activity of TssM ([Fig. 3](#F3){ref-type="fig"}), an observation that differs from the requirement of ATP binding of ExeA in ExeA-ExeB IM complex formation in *Aeromonas hydrophila* T2SS ([@B54]). The evidence that Hcp can only be recruited efficiently into the TssM-TssL complex *in vivo* and *in vitro* in an ATP hydrolysis-dependent manner ([Figs. 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}) strongly argues that TssM plays a direct role in regulating the dynamic interaction of TssL-Hcp via its ATPase activity. This ATP-dependent assembly of the TssM-TssL IM complex with Hcp in T6SS revealed both distinct and similar mechanisms with those in T2SS and T4SS. In T4SS, VirB11 and VirD4 energize the complex formation of VirB10-VirB7-VirB9 to bridge the IM and OM ([@B48]). In T2SS of *A. hydrophila*, the ATPase ExeA forms a complex with the bitopic subunit ExeB in the IM ([@B54]) and bridges the IM and OM through its binding to the peptidoglycan layer and OM secretin ([@B55], [@B56]). In the case of T6SS, it is the TssM-interacting protein TssL or another T6SS IM component, TagL (SciZ), that possess a conserved peptidoglycan-binding motif required for Hcp secretion ([@B57]).^3^ The interaction of the TssM ortholog with the OM protein TssJ (SciN) in enteroaggregative *E. coli* and *E. tarda* leads to the formation of a multiprotein complex linking both IM and OM proteins through peptidoglycan ([@B20], [@B57], [@B58]). TssJ is a *bona fide* T6SS OM protein present in many but not all T6SSs identified to date ([@B59]). Although no proteins homologous to TssJ or any putative OM protein were encoded in the *A. tumefaciens* T6SS gene cluster ([@B9]), we envision that the TssM-TssL IM complex may interact with peptidoglycan via the peptidoglycan-binding motif of TssL and bridge the OM prior to or during the process of Hcp secretion across the OM. It is plausible that TssJ, or other unknown OM components, may resemble the T2SS secretin ExeD, for which multimerization and localization into the OM is energized by the ExeA ATPase ([@B60], [@B61]). The functional and mechanistic similarity of trafficking ATPases in T2SS, T4SS, and T6SS argues for a convergent evolution of ATPase in the bacterial protein secretion systems.

Our observation that TssM is more resistant to protease digestion at higher cellular ATP levels ([Fig. 4](#F4){ref-type="fig"}*A*), whereas the Walker B variant TssM^mWB^ remains protease-resistant at the WT level ([Fig. 6](#F6){ref-type="fig"}*B*), suggests an ATP binding-induced conformational change. This protease-resistant conformational transition induced by ATP binding has also been observed in other trafficking ATPases such as *E. coli* HlyB ([@B62]), *Salmonella typhimurium* MalK ([@B63]), and *E. coli* SecA ([@B64]), suggesting a common and critical feature for ATPases. In addition to ATPases, VirB10 ([@B48]) and TonB ([@B49]) function as energy sensors of the complex in which they undergo a protease-susceptible conformational change when sensing ATP or proton. T2SS ExeB shares sequence and structure similarities with TonB and is protected by ExeA from proteolytic degradation ([@B65]). Interestingly, TssL possesses the common features of an energy sensor, including its interaction with ATPase, a bitopic membrane topology, and a proline-rich region in the C-terminal periplasmic domain ([@B48]), suggesting a possible function for TssL as an energy sensor undergoing a conformational change when sensing ATP-bound TssM. The evidence that TssL is able to interact with Hcp in the absence of TssM but the efficient recruitment of Hcp into TssM-TssL complex requires the ATP hydrolysis activity of TssM ([Figs. 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}*D*) indeed supports the ATP-hydrolysis driven conformation transition of TssL in this ternary complex. The periplasmic domain of TssM may undergo a conformational change when binding to TssL via its N-terminal cytoplasmic domain ([@B36]). It is possible that the periplasmic domain of TssL is only accessible for interaction with Hcp during ATP hydrolysis but may be locked or masked in the absence of ATP hydrolysis conferred by TssM. The TssL periplasmic domain could become wide open when not interacting with TssM and therefore accessible to interact with Hcp. However, we could not detect any protease susceptibility difference in TssL under energy-depleted condition or in the absence of TssM (data no shown). Future studies using fluorescence resonance energy transfer ([@B66]) to detect possible TssL conformational change in real time may allow us to investigate further exactly how TssL senses the input of energy from the cytoplasmic domain of TssM and responds by interacting with Hcp at the periplasm.

Notably, the interaction of Hcp with the C-terminal periplasmic domain but not the N-terminal cytoplasmic domain of TssL in *E. coli* ([Fig. 2](#F2){ref-type="fig"}) suggested that the assembly of TssM-TssL-Hcp occurs in the periplasmic space of *A. tumefaciens*. Hcp localizes mostly in the cytosol but also is present in the cell periphery, including both membranes and the periplasm, based on our previous immunoelectron microscopy ([@B38]) and biochemical fractionation studies.[^4^](#FN5){ref-type="fn"} Moreover, the localization of Hcp in the periplasm is also supported by the presence of Hcp in the periplasmic fraction of various bacteria ([@B67]--[@B70]) and the detection of alkaline phosphatase activity of the *P. aeruginosa* Hcp1-PhoA fusion protein in *E. coli* ([@B28]). However, it remains unclear how Hcp translocates across the IM to the periplasm, as no typical Sec/Tat signal peptide is found in Hcp. A recent study on the export of SodA, a protein lacking a classical signal peptide, to the periplasm in a SecA-dependent but SecB-independent manner in *Rhizobium leguminosarum* ([@B71]) suggests the existence of one or more novel protein translocation mechanisms. Therefore, Hcp may be translocated across the IM to the periplasm via an unconventional pathway and represent an intermediate form of Hcp in the process of building the nanotube-like structure toward the bacterial surface. Even though Hcp can form a hexamer when expressed in *E. coli* ([@B21], [@B68]) or a nanotube stacked in head-to-tail pattern *in vitro* ([@B22]), the nanotube-like structure of Hcp has not been observed *in vivo*. We postulated that TssM energizes the hexameric form of Hcp into the TssM-TssL IM complex at the periplasmic face, where it assembles into a nanotube-like structure with VgrG at the tip to allow the tube protruding out of the OM into the extracellular space. Future detailed biochemical and microscopy analysis of the TssM-TssL-Hcp subcomplex assembly *in vivo* and *in vitro* will illustrate the mechanistic roles of TssM and TssL in Hcp assembly and/or secretion.

TssH and TssM, the T6SS ATPases, are required for Hcp secretion ([@B20], [@B21], [@B26], [@B38]). The AAA+ ATPase TssH (ClpV) interacts with TssB (VipA) and TssC (VipB), and its ATP hydrolysis is crucial for threading the TssB/TssC cogwheel-like tubule, which is similar to the T4 bacteriophage tail sheath structure ([@B26], [@B72]). By analyzing the TssB/TssC tubule variants, Pietrosiuk *et al.* ([@B35]) further document the necessity of TssH-triggered TssB/TssC tubule disassembly for T6SS activity. However, TssH does not interact directly with the secreted exoproteins Hcp and VgrG ([@B26]), which presumably resemble the internal phage tail tube structure assembled underneath tail sheath ([@B73]). TssM also does not interact directly with Hcp but hydrolyzes ATP to drive the assembly of the TssM-TssL-Hcp complex, which may be critical for Hcp secretion across the OM ([Figs. 3](#F3){ref-type="fig"}, [6](#F6){ref-type="fig"}, and [7](#F7){ref-type="fig"}). Therefore, we propose that the T6SS uses two energizers, with TssM powering the assembly of the Hcp nanotube and TssH providing energy for contracting the tail sheath, to push Hcp secretion across the OM. The molecular mechanisms underlying the temporal and spatial coordination of TssM and TssH for T6SS assembly and secretion await future investigation.
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